Carcinoma, Hepatocellular: all 3,249 studies
Page 7 of 33. Open to participants first (974), then studies with results posted, then the rest; newest registration first within each.
- Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular CarcinomaNot yet recruitingNCT06331260
- A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)RecruitingNCT06330064Phase 1/2
- The Diagnostic Efficacy of Glutamine Synthetaseand BCLAF1in Early Diagosis of Hepatocellular Carcinoma in Cirrhotic PatientsNot yet recruitingNCT06328283
- Innovative Diagnosis and Therapy in LDLT Patients With High-risk Hepatocellular CarcinomaRecruitingNCT06327269Early Phase 1
- A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular CarcinomaRecruitingNCT06326502Phase 1
- Value of Dynamic Monitoring of Early Recurrence of Hepatocellular Carcinoma After Radical Resection Based on CTCSNot yet recruitingNCT06317896
- Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402)RecruitingNCT06313190Phase 2
- Precision Adjuvant Therapy After Surgery for Hepatocellular CarcinomaRecruitingNCT06311929Phase 4
- Rituximab Combined With Prior Therapy in Advanced Hepatocellular Carcinoma: Efficacy & Safety StudyRecruitingNCT06301399Phase 2
- A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCCRecruitingNCT06294548Phase 1/2
- Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular CarcinomaRecruitingNCT06285019Phase 2
- A Trial of Cadonilimab Plus Regorafenib in Patients With Hepatocellular Carcinoma Who Failed Camrelizumab Combined With ApatinibRecruitingNCT06280105Phase 2
- Evaluation of AKR1B10 as a New Marker for Interventional Therapy of Hepatocellular CarcinomaRecruitingNCT06272656
- Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary MetastasesRecruitingNCT06265350Not applicable
- Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) ProgramRecruitingNCT06265285Phase 2
- Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver CirrhosisRecruitingNCT06265272
- Combination of SBRT, PD-L1 Inhibitor, and Lenvatinib in Hepatocellular Carcinoma (HSBRT2401)RecruitingNCT06261125Phase 2
- Targeted Navigation in Hepatocellular Carcinoma (HCC)RecruitingNCT06260943Not applicable
- Efficacy and Safety of Intratumoral Injection of Recombinant Human Adenovirus Type 5 Combined With Tislelizumab and Lenvatinib in the Treatment of Advanced Hepatocellular CarcinomaNot yet recruitingNCT06253598Phase 2
- Find HDV and Determine Its Status in TurkeyRecruitingNCT06248580
- Surgical Resection Combined With Intraperitoneal Hyperthermic ChemotherapyNot yet recruitingNCT06247293
- Efficacy and Safety of SBRT Combined With Atezolizumab Plus Bevacizumab vs Atezolizumab Plus Bevacizumab in Treating Unresectable Advance Hepatocellular Carcinoma.Not yet recruitingNCT06244446
- HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）Plus Sintilimab and Donafenib in the First-line Treatment of Unresectable Hepatocellular CarcinomaRecruitingNCT06244225Phase 2
- A Study of MGC026 in Participants With Advanced Solid TumorsRecruitingNCT06242470Phase 1
- Immunotherapy for Hepatocellular CarcinomaRecruitingNCT06241326
- Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver TransplantationRecruitingNCT06236568Not applicable
- A Study Evaluating the Efficacy and Safety of ZG005 in Combination With Donafenib or Bevacizumab in Patients With Advanced Hepatocellular CarcinomaNot yet recruitingNCT06233994Not applicable
- Evaluation of Stereotactic Body Radiotherapy as a Bridge Therapy for Hepatocellular Carcinoma Patients Enlisted for Liver TransplantationRecruitingNCT06218420Phase 2
- Cadonilimab and Lenvatinib for Conversion Therapy in Unresectable Hepatocellular CarcinomaRecruitingNCT06215651Phase 2
- HAIC Combine Tislelizumab and Lenvatinib in the Treatment of HCC With Type IV (Vp4) Portal Vein Tumor Thrombus (HAI-TL)Not yet recruitingNCT06210334Phase 2
- A Retrospective Study on the Treatment of Intermediate and Advanced Liver Cancer.RecruitingNCT06205732
- Phase II Study of Adjuvant SIB Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC.RecruitingNCT06205472Phase 2
- ITGA6 Targeting NIR-II Fluorescence Image Guided SurgeryRecruitingNCT06204835Phase 1
- FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind TrialRecruitingNCT06201065Phase 3
- Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T CellsRecruitingNCT06198296Phase 1
- A Study of Cadonilimab Combined With AK112 as Second-line Therapy in Patients With Advanced Hepatocellular CarcinomaNot yet recruitingNCT06196775Phase 2
- LTFU for All Cell and Gene Therapy StudiesNot yet recruitingNCT06194461
- DEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCCRecruitingNCT06190665Not applicable
- HAIC, Lenvatinib, and Cadonilimab as Conversion Therapy for Initially Unresectable Hepatocellular CarcinomaRecruitingNCT06187961Phase 2
- CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver NodulesRecruitingNCT06184152Not applicable
- A Study of Ga-68 Dolacga to Evaluate Liver Reserve Function in Patients With HCC Before and After Proton TherapyNot yet recruitingNCT06182865Not applicable
- Prospective Cohort Study on Thermal Ablation of Malignant Liver TumorsRecruitingNCT06179602
- Effects of Cognitive Intervention Therapy on Postoperative DeliriumNot yet recruitingNCT06178939Not applicable
- Clinical Research on Dynamic Monitoring MRD Via Plasma ctDNA After Systemic Therapy of Hepatocellular CarcinomaRecruitingNCT06178809
- Radiation Major Hepatectomy to Selectively Treat Large Unifocal Hepatocellular CarcinomaRecruitingNCT06178198Phase 2
- Influence of Sarcopenia in Hepatocellular Carcinoma PatientsNot yet recruitingNCT06177496
- Role of Abbreviated MRI in Follow-up of Hepatocellular Carcinoma .Not yet recruitingNCT06168357
- Radioembolization as a Spearhead Treatment of Hepatocellular Carcinoma With Localized Portal Vein Tumor ThrombosisRecruitingNCT06166576Phase 2
- A Study of [68Ga]Ga-NOTA-RG2 PET Imaging in the Diagnosis of Hepatocellular CarcinomaRecruitingNCT06148155Not applicable
- A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular CarcinomaRecruitingNCT06144385Phase 1
- A Study of HAIC Combined With Lenvatinib and Envolizumab in Potentially Resectable Hepatocellular CarcinomaNot yet recruitingNCT06143579Phase 2
- Treatment of MB07133 Plus Sintilimab in Patients With Hepatocellular CarcinomaRecruitingNCT06141109Phase 1/2
- A Prospective Study on the Application of Liquid Biopsy in the Surveillance of High-risk Population of HCC.RecruitingNCT06134973
- Clinical Study of VG161 Combined With Camrelizumab in Patients With Advanced Primary Hepatocellular CarcinomaNot yet recruitingNCT06124001Phase 1/2
- BC3402 in Combination With Durvalumab in Patients With Advanced Hepatocellular CarcinomaNot yet recruitingNCT06111326Phase 1/2
- Bevacizumab in Combination With Sintilimab Versus Transcatheter Arterial Chemoembolization for the Treatment of Intermediate Stage Hepatocellular Carcinoma (Beyond Up-To-Seven Criteria)RecruitingNCT06090656Phase 2
- A Study to Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical ResectionNot yet recruitingNCT06089382Phase 3
- Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular InvasionNot yet recruitingNCT06089369Phase 3
- NWRD06 DNA Plasmid for HCC After Radical ResectionRecruitingNCT06088459Phase 1
- Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.RecruitingNCT06085976Phase 2
- Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400RecruitingNCT06084481Phase 1
- National Liver Cancer Screening TrialRecruitingNCT06084234Phase 4
- Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) Guided Therapy in Patients With Advanced/ Inoperable Solid TumorsRecruitingNCT06077591Not applicable
- bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular CarcinomaRecruitingNCT06070636Not applicable
- Follow up After TACE by Elastography and Color Doppler.Not yet recruitingNCT06070623
- A Study of Therapeutic Drug Monitoring-Based Atezolizumab DosingRecruitingNCT06066138Phase 1
- Project OASIS: Optimizing Approaches to Select Implementation StrategiesEnrolling by invitationNCT06061328Not applicable
- bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCCRecruitingNCT06061276Not applicable
- Liver Resection and Simultaneous Sleeve Gastrectomy for MS-HCC (LIRESS)Not yet recruitingNCT06060847Not applicable
- Study on the Quantitative Assessment of the Risk of Hepatocellular Carcinoma in Patients With Chronic Liver Disease Using Multi-parameter Magnetic Resonance ImagingRecruitingNCT06060769
- Autologous Natural Killer Cell Therapy for Hepatocellular CarcinomaRecruitingNCT06044506Phase 1
- The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCCNot yet recruitingNCT06042842
- Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver TransplantationNot yet recruitingNCT06041490Phase 2
- Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCCRecruitingNCT06041477Phase 3
- Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor ThrombusRecruitingNCT06040177Phase 1/2
- Comparison of Dexamethasone and N Acetylcysteine (NAC) Versus N Acetylcysteine (NAC) Alone in the Prevention of Post Embolization Syndrome in Patients With Hepatocellular Carcinoma Following Transarterial Chemoembolization.Not yet recruitingNCT06039280Not applicable
- Phase 2 Study of ADI-PEG 20 Plus Lenvatinib Treatment in Subjects With Unresectable Hepatocellular CarcinomaRecruitingNCT06034977Phase 2
- Usability and Clinical Effectiveness of an Interpretable Deep Learning Framework for Post-Hepatectomy Liver Failure PredictionRecruitingNCT06031818
- Anlotinib and TQB2450 in Advanced Hepatocellular Carcinoma After Failure of Prior Immune Checkpoint InhibitorsNot yet recruitingNCT06031480Phase 2
- Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical TrialRecruitingNCT06031285Phase 2
- The Clinical Significance of Peripheral Blood T Lymphocyte PD-1 Expression and T Cell Subset Distribution.RecruitingNCT06029829Phase 2
- A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)RecruitingNCT06028724
- Efficacy, Safety, and Treatment Patterns of Transcatheter Arterial Chemoembolization (TACE) Combined With Atezolizumab and Bevacizumab in Unresectable Hepatocellular Carcinoma: a Multicenter, Retrospective, Observational Real-world StudyNot yet recruitingNCT06024252
- A Real-world Study of the Short-term Efficacy and Safety of E-TACE in Patients With Hepatocellular Carcinoma (HCC)Not yet recruitingNCT06023147Not applicable
- EGCG for Hepatocellular Carcinoma ChemopreventionRecruitingNCT06015022Phase 2
- A Prospective Study of Memantine in Patients With Cirrhosis and Liver CancerRecruitingNCT06007846Phase 2/3
- A Clinical Study of Tislelizumab Combined With TACE and Lenvatinib in the Neoadjuvant Treatment of Resectable HCCRecruitingNCT06003673Phase 4
- Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAICRecruitingNCT06001567Phase 2
- SIRT for Potentially Resectable HCCRecruitingNCT05994859Not applicable
- Lenvatinib, Sintilimab Plus SIRT for Unresectable HCCRecruitingNCT05992584Phase 2
- Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular InvasionRecruitingNCT05992220Phase 2
- Risk Factors, Prognosis, and Potential Chemoprevention Drugs in Patients With Recurrent Hepatocellular Carcinoma After Curative Surgeries: a Nationwide Retrospective Cohort Study and a Multi-center Prospective Cohort AnalysisRecruitingNCT05990959
- Multimodal Ultrasound and Hepatocellular Response to Local TreatmentsRecruitingNCT05987514Not applicable
- Sintilimab+Bevacizumab+TACE vs. Lenvatinib+TACE for Advanced HCCRecruitingNCT05985798Phase 3
- TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTTRecruitingNCT05984511Not applicable
- A Clinical Study of mRNA Vaccine (ABOR2014/IPM511) in Patients With Advanced Hepatocellular CarcinomaRecruitingNCT05981066Not applicable
- A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular CarcinomaNot yet recruitingNCT05976568Phase 2/3
- Hepatic Artery Infusion of Adebrelimab Combined With Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma With Failure of Systemic Therapy Combined With Interventional TherapyNot yet recruitingNCT05975463Phase 2
- Resection And Partial LIver Transplantation With Delayed Hepatectomy for Hepatocellular CarcinomaNot yet recruitingNCT05971628Not applicable
- Phase II Study of Fruquintinib Combined With Sintilimab and TACE for Inoperable Primary Hepatocellular CarcinomaRecruitingNCT05971199Phase 2